Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) EPS (Basic) (2016 - 2022)

Edesa Biotech's EPS (Basic) history spans 9 years, with the latest figure at -$0.33 for Q4 2021.

  • For Q4 2021, EPS (Basic) fell 26.92% year-over-year to -$0.33; the TTM value through Dec 2021 reached -$1.17, down 46.25%, while the annual FY2025 figure was -$1.27, 34.2% up from the prior year.
  • EPS (Basic) for Q4 2021 was -$0.33 at Edesa Biotech, down from -$0.29 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.17 in Q3 2018 and bottomed at -$2.34 in Q3 2017.
  • The 5-year median for EPS (Basic) is -$0.26 (2018), against an average of -$0.42.
  • The largest annual shift saw EPS (Basic) tumbled 1700.0% in 2017 before it surged 107.26% in 2018.
  • A 5-year view of EPS (Basic) shows it stood at -$0.93 in 2017, then skyrocketed by 88.17% to -$0.11 in 2018, then tumbled by 36.36% to -$0.15 in 2019, then plummeted by 73.33% to -$0.26 in 2020, then fell by 26.92% to -$0.33 in 2021.
  • Per Business Quant, the three most recent readings for EDSA's EPS (Basic) are -$0.33 (Q4 2021), -$0.29 (Q3 2021), and -$0.36 (Q2 2021).